(Q53073350)

11 May 2018

title

Amyloid-β aggregation with gold nanoparticles on brain lipid bilayer. (English)

1 reference

11 May 2018

0 references

4

Jwa-Min Nam

1 reference

11 May 2018

author name string

Hyojin Lee

series ordinal

1

1 reference

11 May 2018

Yuna Kim

series ordinal

2

1 reference

11 May 2018

Anna Park

series ordinal

3

1 reference

11 May 2018

publication date

24 March 2014

1 reference

11 May 2018

published in

Small

1 reference

11 May 2018

volume

10

1 reference

11 May 2018

issue

9

1 reference

11 May 2018

page(s)

1779-1789

1 reference

11 May 2018

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

cites work

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Alzheimer's disease: clinical trials and drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Unfolding the role of protein misfolding in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Physicochemical interactions of amyloid beta-peptide with lipid bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Gold nanoparticles can induce the formation of protein-based aggregates at physiological pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Influence of Nanoparticle Size and Shape on Oligomer Formation of an Amyloidogenic Peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Nanomechanics of functional and pathological amyloid materials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Self-assembled peptide-polyoxometalate hybrid nanospheres: two in one enhances targeted inhibition of amyloid β-peptide aggregation associated with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Using graphene oxide high near-infrared absorbance for photothermal treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

New method based on capillary electrophoresis with laser-induced fluorescence detection (CE-LIF) to monitor interaction between nanoparticles and the amyloid-β peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Gold nanoshell bioconjugates for molecular imaging in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Protein aggregation diseases: pathogenicity and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Protein misfolding, functional amyloid, and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Biosensor-based label-free assays of amyloid growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Pathways towards and away from Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Restriction of receptor movement alters cellular response: physical force sensing by EphA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Model membrane systems and their applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Nucleation of protein fibrillation by nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

A molecular ruler based on plasmon coupling of single gold and silver nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Biosensing with plasmonic nanosensors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Altered TCR signaling from geometrically repatterned immunological synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Lipid lateral mobility and membrane phase structure modulation by protein binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Nanostructures in biodiagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Understanding biophysicochemical interactions at the nano-bio interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Nanoparticles as catalysts for protein fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Effect of nanoparticles on protein folding and fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Effect of surfaces on amyloid fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Molecular structural basis for polymorphism in Alzheimer's -amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Aggregating the amyloid Abeta(11-25) peptide into a four-stranded beta-sheet structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Aggregation and interaction of cationic nanoparticles on bacterial surfaces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

Effect of surface treatment on diffusion and domain formation in supported lipid bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303242

21 January 2018

Identifiers

DOI

10.1002/SMLL.201303242

1 reference

11 May 2018

1 reference

11 May 2018